Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Vulvovaginal Atrophy”

99 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 99 results

Post-approval studies (Phase 4)Study completedNCT02784613
What this trial is testing

Vulvoscopy Changes of the Vulva, Vestibule and Vagina With Daily Ospemifene in Women With Dyspareunia From VVA

Who this might be right for
Vulvovaginal AtrophyDyspareunia
Sue Goldstein 10
Testing effectiveness (Phase 2)Study completedNCT02449902
What this trial is testing

TXV13-01 Estradiol Vaginal Softgel Capsules in Treating Postmenopausal Women With Symptoms of Vulvar and Vaginal Atrophy

Who this might be right for
MenopauseVulvovaginal AtrophyPainful Intercourse+1 more
TherapeuticsMD 50
Not applicableUnknownNCT03628092
What this trial is testing

Laser Therapy for Vulvovaginal Symptoms in Breast Cancer Patients

Who this might be right for
Vulvovaginal AtrophyGenitourinary Symptoms and Ill-Defined Conditions
Royal North Shore Hospital 70
Large-scale testing (Phase 3)Study completedNCT01400776
What this trial is testing

Safety & Efficacy WC3011 (Estradiol Vaginal Cream) in the Treatment of Vulvovaginal Atrophy in Postmenopausal Women

Who this might be right for
Postmenopausal Vulvovaginal Atrophy
Warner Chilcott 722
Large-scale testing (Phase 3)Study completedNCT04232813
What this trial is testing

Evaluation of the Acceptability and Efficacy of 10 Micrograms of Estradiol Vaginal Tablets vs Promestriene Vaginal Cream

Who this might be right for
Vulvovaginal Atrophy
Instituto Palacios 120
Not applicableStudy completedNCT05692960
What this trial is testing

Women's Interventions for Sexual Health: WISH

Who this might be right for
Sexual Dysfunction, PhysiologicalBody ImageLibido; Loss, Aversion
The University of Tennessee, Knoxville 30
Not applicableStudy completedNCT03083262
What this trial is testing

High Tone Pelvic Floor Dysfunction

Who this might be right for
Vulvovaginal Atrophy
St. Louis University 80
Large-scale testing (Phase 3)Study completedNCT02013544
What this trial is testing

Intravaginal Prasterone (DHEA) Against Vulvovaginal Atrophy Associated With Menopause

Who this might be right for
Vaginal Atrophy
EndoCeutics Inc. 558
Testing effectiveness (Phase 2)WithdrawnNCT04487392
What this trial is testing

Photobiomodulation Effect on Vulvovaginal Atrophy in Postmenopausal Women.

Who this might be right for
Vulvovaginal Atrophy
University of Nove de Julho
Not applicableStudy completedNCT02966925
What this trial is testing

Autologous Platelet Concentrate Combined to Hyaluronic Acid Obtained With Cellular Matrix® BCT-HA Kit and Vulvovaginal Dryness

Who this might be right for
Vulvar Atrophy
Regen Lab SA 20
Not applicableStudy completedNCT04735549
What this trial is testing

Vulvovaginal Atrophy Correction Using Neodymium Laser

Who this might be right for
Postmenopausal PeriodVaginal AtrophyFemale Urogenital Diseases
MeLSyTech, Ltd 120
Not applicableLooking for participantsNCT06962345
What this trial is testing

Changes in the Impact of Genitourinary Syndrome of Menopause With a Novel Nonhormonal Vulvovaginal Gel Assessed by PROMs.

Who this might be right for
Vulvar AtrophyVulvovaginal Signs and SymptomsGenitourinary Syndrome of Menopause+7 more
Mucosa Innovations, S.L. 80
Not applicableStudy completedNCT03557398
What this trial is testing

Efficacy and Safety of HYDEAL-D Vaginal Pessaries Application on the Treatment of Vaginal Atrophy in Post-menopause Women

Who this might be right for
Vulvovaginal Atrophy
Fidia Farmaceutici s.p.a. 40
Testing effectiveness (Phase 2)Study completedNCT07306611
What this trial is testing

Regenerative Treatment of Female Genital Atrophy

Who this might be right for
Vulvo Vaginal Atrophy
AndreiaAntunes 30
Large-scale testing (Phase 3)UnknownNCT03782480
What this trial is testing

Examining Effects of Intrarosa in Women With Genitourinary Syndrome of Menopause/Vulvovaginal Atrophy

Who this might be right for
MenopauseGenitourinary Syndrome of MenopauseVulvovaginal Atrophy+2 more
Center for Vulvovaginal Disorders 40
Post-approval studies (Phase 4)Active Not RecruitingNCT05562518
What this trial is testing

GRACE-trial: a Randomized Active-controlled Trial for vulvovaGinal atRophy in breAst Cancer Patients on Endocrine Therapy.

Who this might be right for
Vulvovaginal AtrophyBreast Cancer
University Hospital, Ghent 160
Not applicableStudy completedNCT04766957
What this trial is testing

Pilot Clinical Trial of IDRACARE® in Moderate to Severe Symptoms of Vulvovaginal Atrophy

Who this might be right for
Vulvovaginal Atrophy
Procare Health Iberia S.L. 134
Not applicableStudy completedNCT05398172
What this trial is testing

Clinical Evaluation of Fractional Bi-Polar Radio-Frequency for Symptoms of Vulvovaginal Atrophy

Who this might be right for
Vaginal Atrophy
InMode MD Ltd. 30
Not applicableStudy completedNCT01899612
What this trial is testing

Vaginal Inflammation Markers in Postmenopausal Women With and Without Symptoms of Vaginal Inflammation

Who this might be right for
MenopauseVaginal Atrophy
Insel Gruppe AG, University Hospital Bern 16
Not applicableUnknownNCT04657536
What this trial is testing

Evaluating the Efficacy of Temperature-controlled Radiofrequency (TRF) in the Treatment of Vulvovaginal Atrophy.

Who this might be right for
Postmenopausal Vulvovaginal Atrophy
Peking University People's Hospital 200
Load More Results